Cart
sales@molnova.com
IVA-337
CAS No. 927961-18-0
IVA-337( Lanifibranor | IVA337 )
Catalog No. M16646 CAS No. 927961-18-0
IVA-337 (Lanifibranor, IVA337)) is a potent, pan PPAR agonist with EC50 of 0.92 uM, 0.53 uM and 0.18 uM for human PPARα, PPARδ and PPARγ respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 31 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 176 | In Stock |
|
| 50MG | 322 | In Stock |
|
| 100MG | 485 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIVA-337
-
NoteResearch use only, not for human use.
-
Brief DescriptionIVA-337 (Lanifibranor, IVA337)) is a potent, pan PPAR agonist with EC50 of 0.92 uM, 0.53 uM and 0.18 uM for human PPARα, PPARδ and PPARγ respectively.
-
DescriptionIVA-337 (Lanifibranor, IVA337)) is a potent, pan PPAR agonist with EC50 of 0.92 uM, 0.53 uM and 0.18 uM for human PPARα, PPARδ and PPARγ respectively; reduces skin fibrosis in the mouse, and suppresses inflammation in vivo.Steatohepatitis,Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsLanifibranor | IVA337
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research AreaOther Indications
-
IndicationSteatohepatitis
Chemical Information
-
CAS Number927961-18-0
-
Formula Weight434.909
-
Molecular FormulaC19H15ClN2O4S2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL 229.93 mM
-
SMILESO=C(O)CCCC(N1S(=O)(C2=CC=C3N=CSC3=C2)=O)=CC4=C1C=CC(Cl)=C4
-
Chemical Name4-(1-(1,3-Benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl)butanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ruzehaji N, et al. Ann Rheum Dis. 2016 Dec;75(12):2175-2183.
2. Avouac J, et al. Ann Rheum Dis. 2017 Aug 11. pii: annrheumdis-2016-210821.
molnova catalog
related products
-
ARH-049020
ARH-049020 (ARH049020) is a PPAR agonist used in the study of type 2 diabetes.
-
Growth hormone relea...
Growth hormone releasing peptide ia a natual product and has anti-inflammatory effects due to its inhibitory effect on PKC-induced activation of p38 JNK and NF-κB possibly by targeting to MKP-1 and PP2A.
-
BAY-0069
BAY-0069 is a potent and selective PPARγ transactivator, inhibiting human PPARγ and murine PPARγ with IC50 values of 6.3 nM and 24 nM, respectively. BAY-0069 can be used in cancer research.
